Logo image of MRK

MERCK & CO. INC. (MRK) Stock Overview

USA - NYSE:MRK - US58933Y1055 - Common Stock

78.56 USD
+0.96 (+1.24%)
Last: 9/26/2025, 8:13:36 PM
78.6784 USD
+0.12 (+0.15%)
After Hours: 9/26/2025, 8:13:36 PM

MRK Key Statistics, Chart & Performance

Key Statistics
52 Week High114.79
52 Week Low73.31
Market Cap196.23B
Shares2.50B
Float2.50B
Yearly Dividend3.1
Dividend Yield4.07%
EPS(TTM)7.7
PE10.2
Fwd PE8.09
Earnings (Next)10-30 2025-10-30/bmo
IPO01-01 1941-01-01
Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryPharmaceuticals


MRK short term performance overview.The bars show the price performance of MRK in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -2 -4 -6 -8 -10

MRK long term performance overview.The bars show the price performance of MRK in the last 1, 2 and 3 years. 1 year 2 years 3 years -10 -20 -30

The current stock price of MRK is 78.56 USD. In the past month the price decreased by -5.59%. In the past year, price decreased by -30.9%.

MERCK & CO. INC. / MRK Daily stock chart

MRK Competitors/Peers

The largest stocks on the US markets in the "Pharmaceuticals" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
LLY ELI LILLY & CO 44.86 685.75B
JNJ JOHNSON & JOHNSON 17.97 432.80B
NVO NOVO-NORDISK A/S-SPONS ADR 14.15 247.10B
NVS NOVARTIS AG-SPONSORED ADR 13.97 239.37B
AZN ASTRAZENECA PLC-SPONS ADR 16.61 228.69B
PFE PFIZER INC 7.01 135.09B
SNY SANOFI-ADR 10.21 111.07B
BMY BRISTOL-MYERS SQUIBB CO 6.56 89.80B
GSK GSK PLC-SPON ADR 8.86 80.28B
ZTS ZOETIS INC 23.07 63.60B
TAK TAKEDA PHARMACEUTIC-SP ADR 50.83 46.55B
HLN HALEON PLC-ADR 18 39.54B

About MRK

Company Profile

MRK logo image Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. The company is headquartered in Rahway, New Jersey and currently employs 75,000 full-time employees. The firm's segments include Pharmaceutical and Animal Health. Pharmaceutical segment includes human health pharmaceutical and vaccine products. The firm sells its human health pharmaceutical products primarily to drug wholesalers and retailers, hospitals, government agencies and managed health care providers. The company sells its human health vaccines primarily to physicians, wholesalers, distributors and government entities. Animal Health segment discovers, develops, manufactures and markets a range of veterinary pharmaceutical and vaccine products, as well as health management solutions and services, for the prevention, treatment and control of disease in all major livestock and companion animal species. The company sells its products to veterinarians, distributors, animal producers, farmers and pet owners.

Company Info

MERCK & CO. INC.

126 East Lincoln Avenue, P.O. Box 2000

Rahway NEW JERSEY 07033 US

CEO: Kenneth C. Frazier

Employees: 75000

MRK Company Website

MRK Investor Relations

Phone: 19087404000

MERCK & CO. INC. / MRK FAQ

What is the stock price of MERCK & CO. INC. today?

The current stock price of MRK is 78.56 USD. The price increased by 1.24% in the last trading session.


What is the ticker symbol for MERCK & CO. INC. stock?

The exchange symbol of MERCK & CO. INC. is MRK and it is listed on the New York Stock Exchange, Inc. exchange.


On which exchange is MRK stock listed?

MRK stock is listed on the New York Stock Exchange, Inc. exchange.


What is the price forecast or stock price prediction for MERCK & CO. INC. stock?

33 analysts have analysed MRK and the average price target is 101.66 USD. This implies a price increase of 29.4% is expected in the next year compared to the current price of 78.56. Check the MERCK & CO. INC. stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is MERCK & CO. INC. worth?

MERCK & CO. INC. (MRK) has a market capitalization of 196.23B USD. This makes MRK a Large Cap stock.


How many employees does MERCK & CO. INC. have?

MERCK & CO. INC. (MRK) currently has 75000 employees.


What are the support and resistance levels for MERCK & CO. INC. (MRK) stock?

MERCK & CO. INC. (MRK) has a support level at 78.28 and a resistance level at 82.17. Check the full technical report for a detailed analysis of MRK support and resistance levels.


Is MERCK & CO. INC. (MRK) expected to grow?

The Revenue of MERCK & CO. INC. (MRK) is expected to grow by 1.18% in the next year. Check the estimates tab for more information on the MRK EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy MERCK & CO. INC. (MRK) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does MERCK & CO. INC. (MRK) stock pay dividends?

MERCK & CO. INC. (MRK) has a dividend yield of 4.07%. The yearly dividend amount is currently 3.1. Check the full fundamental report for a detailed analysis of MRK dividend history, reliability and sustainability.


When does MERCK & CO. INC. (MRK) report earnings?

MERCK & CO. INC. (MRK) will report earnings on 2025-10-30, before the market open.


What is the Price/Earnings (PE) ratio of MERCK & CO. INC. (MRK)?

The PE ratio for MERCK & CO. INC. (MRK) is 10.2. This is based on the reported non-GAAP earnings per share of 7.7 and the current share price of 78.56 USD. Check the full fundamental report for a full analysis of the valuation metrics for MRK.


What is the Short Interest ratio of MERCK & CO. INC. (MRK) stock?

The outstanding short interest for MERCK & CO. INC. (MRK) is 0.95% of its float. Check the ownership tab for more information on the MRK short interest.


MRK Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

MRK Fundamental Analysis

ChartMill assigns a fundamental rating of 7 / 10 to MRK. Both the health and profitability get an excellent rating, making MRK a very profitable company, without any liquidiy or solvency issues.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

MRK Financial Highlights

Over the last trailing twelve months MRK reported a non-GAAP Earnings per Share(EPS) of 7.7. The EPS increased by 18.28% compared to the year before.


Industry RankSector Rank
PM (TTM) 25.79%
ROA 13.96%
ROE 33.49%
Debt/Equity 0.69
Chartmill High Growth Momentum
EPS Q2Q%-3.95%
Sales Q2Q%-1.9%
EPS 1Y (TTM)18.28%
Revenue 1Y (TTM)1.82%

MRK Forecast & Estimates

33 analysts have analysed MRK and the average price target is 101.66 USD. This implies a price increase of 29.4% is expected in the next year compared to the current price of 78.56.

For the next year, analysts expect an EPS growth of 17.86% and a revenue growth 1.18% for MRK


Analysts
Analysts75.76
Price Target101.66 (29.4%)
EPS Next Y17.86%
Revenue Next Year1.18%

MRK Ownership

Ownership
Inst Owners80.53%
Ins Owners0.05%
Short Float %0.95%
Short Ratio2